Tamoxifen And Coffee Consumption May Help Prevent Return Of Breast Cancer
4/28/2013
Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts...
Reviving A Foe Of Cancer
4/27/2013
New research reveals how the tumor suppressor p53 is shut down in metastatic melanoma--and how it can be revived Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53...
Certain patients with cancer at risk for malnutrition may improve survival rates, response to treatment and quality of life by receiving nutrition therapy at home, according to information in a Walgreens Infusion Services'(NYSE: WAG) (Nasdaq: WAG) presentation today at the Oncology Nursing Society's 38th Annual Congress in Washington, D.C...
Inherited Endocrine Tumor Syndrome Linked To Much-Studied Cell Pathway
4/27/2013
A mutation in a protein called menin causes a hereditary cancer syndrome called MEN1 (multiple endocrine neoplasia type 1). Individuals with MEN1 are at a substantially increased risk of developing neuroendocrine tumors, including cancer of the pancreatic islet cells that secrete insulin...
Effective Leukemia Drugs Too Expensive, Desperate Patients Left Untreated
4/26/2013
Eleven of the 12 drugs approved for treating chronic myeloid leukemia (CML) and some other cancers cost over $100,000 per year, leaving many desperate patients either untreated or under-treated because they simply cannot afford care, nearly 120 CML experts from over 15 countries reported today in the journal Blood...
Study Suggests Women On Medicaid More Likely To Receive Mastectomy To Treat Breast Cancer
4/26/2013
JAMA Surgery Study Highlights In a study reported in the resident's forum, Linda Adepoju, M.D., of University of Toledo Medical Center, Ohio, and colleagues suggest that tumor size, cancer stage, and Medicaid insurance were predictors of undergoing a mastectomy to treat breast cancer...
Study Examines Treatment Delays In Young Women With Breast Cancer By Race/Ethnicity
4/26/2013
Young women with breast cancer who experience a longer treatment delay time (TDT) have significantly decreased survival time compared with those with a shorter TDT, especially African-American women, those with public or no insurance, and those with low socioeconomic status, according to a report published Online First by JAMA Surgery, a JAMA Network publication...
Using Genetic Variants To Personalize Prostate Cancer Screenings
4/26/2013
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine®. Personalized PSA testing using genetic variants could account for an 18 percent reduction in the number of men who likely would have undergone unnecessary biopsies, according to the study...
Cancer Cells' Achilles' Heel Revealed
4/26/2013
Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells...
Outlook For Minority, Uninsured Pediatric Retinoblastoma Patients Worsened By Delays In Diagnosis
4/26/2013
When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) researchers report at the 26th annual meeting of th...